Caterna Vision GmbH
1 known investors
Caterna offers a digital therapy for children with amblyopia (lazy eye), combining occlusion with its patented FAVAS (Focal Ambient Visual Acuity Stimulation) to train the weaker eye through games played at home on a tablet, laptop, or computer. Developed at the Technical University of Dresden, it is a CE-certified Class 1 medical device prescribed by physicians and used alongside teleophthalmology support.
Digital HealthHealthtechMedical Devices
Investors Β· 1
In the news
Frequently asked questions
- What does Caterna Vision GmbH do?
- Caterna offers a digital therapy for children with amblyopia (lazy eye), combining occlusion with its patented FAVAS (Focal Ambient Visual Acuity Stimulation) to train the weaker eye through games played at home on a tablet, laptop, or computer. Developed at the Technical University of Dresden, it is a CE-certified Class 1 medical device prescribed by physicians and used alongside teleophthalmology support.
- Who are Caterna Vision GmbH's investors?
- Caterna Vision GmbH's investors include Brandenburg Kapital.